Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), a lung disease that may progress to systemic organ involvement and in some cases, death. The identification of the earliest predictors of progressive lung disease would allow for therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiong, MacArthur, Michael R., He, Xinliang, Wei, Xiaoshan, Zarin, Payam, Hanna, Bola S., Wang, Zi-Hao, Xiang, Xuan, Fish, Eleanor N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824252/
https://www.ncbi.nlm.nih.gov/pubmed/33396578
http://dx.doi.org/10.3390/v13010044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824252/
https://www.ncbi.nlm.nih.gov/pubmed/33396578
http://dx.doi.org/10.3390/v13010044

Ejemplares similares